PubMed:33195060 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue ForCovid19 tao:has_database_id
T52 0-9 Interrupt denotes Hijacking
T7 10-20 Species denotes SARS-CoV-2 Tax:2697049
T17 21-25 Gene denotes ACE2 Gene:59272
T51 35-46 Bind denotes Interaction
T26 77-86 Chemical denotes Steroidal drug D013256
T21 130-153 Biological denotes Receptor Binding Domain
T3 159-183 Disease denotes coronavirus disease 2019 MESH:C000657245
T1 185-193 Disease denotes COVID-19 MESH:C000657245
T25 200-227 Disease denotes respiratory tract infection D012141
T6 242-300 Species denotes severe acute respiratory syndrome coronavirus (SARS)-CoV-2 Tax:2697049
T30 459-477 Chemical denotes natural substances drug
T31 482-508 Chemical denotes clinically available drugs drug
T4 527-538 Species denotes SARS-CoV2-2 Tax:2697049
T37 638-655 Biological denotes druggable pockets
T38 671-691 Biological denotes central β-sheet core
T8 699-709 Species denotes SARS-CoV-2 Tax:2697049
T23 710-725 Gene denotes Spike's protein Gene:43740568
T10 726-749 Biological denotes receptor binding domain
T11 751-754 Biological denotes RBD
T35 773-782 Condition denotes in silico
T28 861-873 Chemical denotes triterpenoid drug D014315
T27 874-883 Chemical denotes steroidal drug D013256
T32 896-903 Interrupt denotes inhibit
T34 904-915 Bind denotes interaction
T22 923-928 Gene denotes Spike Gene:43740568
T12 929-932 Biological denotes RBD
T36 942-965 Biological denotes carboxypeptidase domain
T20 973-1002 Gene denotes Angiotensin Converting Enzyme Gene:59272
T16 1004-1008 Gene denotes ACE2 Gene:59272
T13 1084-1087 Biological denotes RBD
T5 1095-1105 Species denotes SARS CoV-2 Tax:2697049
T24 1106-1119 Gene denotes Spike protein Gene:43740568
T14 1183-1186 Biological denotes RBD
T18 1202-1206 Gene denotes ACE2 Gene:59272
T29 1272-1285 Chemical denotes triterpenoids drug D014315
T41 1294-1308 Chemical denotes glycyrrhetinic D006034
T42 1313-1328 Chemical denotes oleanolic acids D009828
T39 1323-1328 Chemical denotes acids D006034
T40 1363-1373 Chemical denotes bile acids MESH:D001647
T44 1363-1373 Chemical denotes bile acids
T43 1384-1404 Chemical denotes amidated derivatives
T46 1413-1418 Glycan denotes glyco
T45 1419-1439 Chemical denotes ursodeoxycholic acid MESH:D014580
T48 1444-1470 Chemical denotes semi-synthetic derivatives
T47 1479-1495 Chemical denotes obeticholic acid MESH:C464660
T49 1496-1503 NegativeRegulation denotes reduces
T15 1508-1511 Biological denotes RBD
T19 1512-1516 Gene denotes ACE2 Gene:59272
T50 1517-1524 Bind denotes binding
T2 1595-1603 Disease denotes COVID-19 MESH:C000657245
T9 1613-1623 Species denotes SARS-CoV-2 Tax:2697049
T33 1630-1640 Chemical denotes inhibitors inhibitor|drug
R1 T1 T3 abbreviation COVID-19,coronavirus disease 2019
R10 T32 T34 is_a inhibit,interaction
R11 T5 T24 of_a SARS CoV-2,Spike protein
R12 T22 T12 of_a Spike,RBD
R13 T24 T13 of_a Spike protein,RBD
R14 T32 T35 has_status inhibit,in silico
R15 T11 T10 abbreviation RBD,receptor binding domain
R16 T8 T23 of_a SARS-CoV-2,Spike's protein
R17 T23 T10 of_a Spike's protein,receptor binding domain
R18 T10 T38 of_a receptor binding domain,central β-sheet core
R19 T38 T37 of_a central β-sheet core,druggable pockets
R2 T6 T3 cause_of severe acute respiratory syndrome coronavirus (SARS)-CoV-2,coronavirus disease 2019
R20 T20 T36 of_a Angiotensin Converting Enzyme,carboxypeptidase domain
R21 T41 T39 - glycyrrhetinic,acids
R22 T46 T45 with glyco,ursodeoxycholic acid
R23 T44 T43 - bile acids,amidated derivatives
R24 T15 T50 of_a RBD,binding
R25 T19 T50 to ACE2,binding
R26 T49 T50 is_a reduces,binding
R27 T29 T49 is_a triterpenoids,reduces
R28 T41 T49 is_a glycyrrhetinic,reduces
R29 T42 T49 is_a oleanolic acids,reduces
R3 T25 T3 is_a respiratory tract infection,coronavirus disease 2019
R30 T40 T49 is_a bile acids,reduces
R31 T44 T49 is_a bile acids,reduces
R32 T45 T49 is_a ursodeoxycholic acid,reduces
R33 T48 T49 is_a semi-synthetic derivatives,reduces
R34 T47 T49 is_a obeticholic acid,reduces
R35 T9 T2 cause_of SARS-CoV-2,COVID-19
R36 T2 T33 against COVID-19,inhibitors
R37 T4 T31 against SARS-CoV2-2,clinically available drugs
R38 T4 T30 against SARS-CoV2-2,natural substances
R39 T7 T51 is_a SARS-CoV-2,Interaction
R4 T16 T20 abbreviation ACE2,Angiotensin Converting Enzyme
R40 T17 T51 to ACE2,Interaction
R41 T26 T52 is_a Steroidal,Hijacking
R42 T52 T51 is_a Hijacking,Interaction
R5 T28 T32 is_a triterpenoid,inhibit
R6 T27 T32 is_a steroidal,inhibit
R7 T22 T34 is_a Spike,interaction
R8 T20 T34 to Angiotensin Converting Enzyme,interaction